Publikationen
| 1. | Incensole acetate: a novel neuroprotective agent isolated from Boswellia carterii. Moussaieff A, Shein NA, Tsenter J, Grigoriadis S, Simeonidou C, Alexandrovich AG, Trembovler V, Ben-Neriah Y, Schmitz ML, Fiebich BL, Munoz E, Mechoulam R, Shohami E
J Cereb Blood Flow Metab. 2008 Jul;28(7):1341-52.
|
| 2. | Co-administration of acetyl-11-keto-beta-boswellic acid, a specific 5-lipoxygenase inhibitor, potentiates the protective effect of COX-2 inhibitors in kainic acid-induced neurotoxicity in mice. Bishnoi M, Patil CS, Kumar A, Kulkarni SK
Pharmacology. 2007;79(1):34-41.
|
| 3. | Dietary support with Boswellia resin in canine inflammatory joint and spinal disease. Reichling J, Schmökel H, Fitzi J, Bucher S, Saller R
Schweiz Arch Tierheilkd. 2004 Feb;146(2):71-9.
|
| 4. | Effects of boswellic acids extracted from a herbal medicine on the biosynthesis of leukotrienes and the course of experimental autoimmune encephalomyelitis. Wildfeuer A, Neu IS, Safayhi H, Metzger G, Wehrmann M, Vogel U, Ammon HP
Arzneimittelforschung. 1998 Jun;48(6):668-74.
|